ELDN: Eledon Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ELDN: Eledon Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 239.55
Enterprise Value ($M) 232.80
Book Value ($M) 76.06
Book Value / Share 1.27
Price / Book 3.15
NCAV ($M) 42.99
NCAV / Share 0.72
Price / NCAV 5.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.24

Liquidity (mrq)
Quick Ratio 6.53
Current Ratio 6.53

Balance Sheet (mrq) ($M)
Current Assets 81.51
Assets 114.58
Liabilities 38.52
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Armistice Capital, Llc 5.96 -3.22
11-05 13G Frazier Life Sciences Public Fund, L.P. 6.10
11-05 13G Ra Capital Management, L.p. 6.10
10-31 13G/A Biotechnology Value Fund L P 10.50 45.45
02-14 13G/A Cormorant Asset Management, LP 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-19 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-19 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 2)
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-25 23,802 136,508 17.44
2024-11-22 51,176 173,116 29.56
2024-11-21 37,784 148,697 25.41
2024-11-20 49,117 416,100 11.80

(click for more detail)

Similar Companies
DWTX – Dogwood Therapeutics, Inc. DYAI – Dyadic International, Inc.
EDSA – Edesa Biotech, Inc. ELTX – Elicio Therapeutics, Inc.
ELUT – Elutia Inc.


Financial data and stock pages provided by
Fintel.io